Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 16 (11) , 1342-1347
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Characteristics and determinants of restless legs syndrome in pregnancyNeurology, 2013
- European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research SocietyEuropean Journal of Neurology, 2012
- When gender matters: Restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study GroupSleep Medicine Reviews, 2012
- UK guidelines on the management of iron deficiency in pregnancyBritish Journal of Haematology, 2012
- Restless legs syndrome during pregnancy in Brazilian womenSleep Medicine, 2010
- Restless Legs Syndrome and Pregnancy: Follow-Up of Pregnant Women before and after DeliveryEuropean Neurology, 2010
- Restless legs syndrome and pregnancyNeurology, 2004
- Restless legs syndrome: diagnostic criteria, special considerations, and epidemiologySleep Medicine, 2003
- Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteriaMovement Disorders, 1997
- Toward a better definition of the restless legs syndromeMovement Disorders, 1995